Baudax Bio Inc. [NASDAQ: BXRX] traded at a low on 11/18/20, posting a -6.78 loss after which it closed the day’ session at $1.10. The company report on November 9, 2020 that Baudax Bio Inc to Host Earnings Call.
Baudax Bio Inc (NASDAQ:BXRX) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 9, 2020 at 9:00 AM Eastern Time.
To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/71189.
The results of the trading session contributed to over 1250390 shares changing hands. Over the past one week, the price volatility of Baudax Bio Inc. stands at 8.38% while the volatility over the past one month is 11.00%.
The market cap for BXRX stock reached $27.80 million, with 18.38 million shares outstanding and 13.41 million shares in the current float. Compared to the average trading volume of 852.53K shares, BXRX reached a trading volume of 1250390 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Baudax Bio Inc. [BXRX]?
JMP Securities have made an estimate for Baudax Bio Inc. shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on May 15, 2020.
The Average True Range (ATR) for Baudax Bio Inc. is set at 0.15, with the Price to Sales ratio for BXRX stock in the period of the last 12 months amounting to 69.49.
How has BXRX stock performed recently?
Baudax Bio Inc. [BXRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.80. With this latest performance, BXRX shares dropped by -30.38% in over the last four-week period, additionally sinking by -72.36% over the last 6 months – not to mention a drop of -79.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BXRX stock in for the last two-week period is set at 27.50, with the RSI for the last a single of trading hit 34.54, and the three-weeks RSI is set at 30.43 for Baudax Bio Inc. [BXRX]. The present Moving Average for the last 50 days of trading for this stock 2.1998, while it was recorded at 1.1140 for the last single week of trading, and 3.5869 for the last 200 days.
Baudax Bio Inc. [BXRX]: Deeper insight into the fundamentals
Reflecting on the efficiency of the workforce at the company, Baudax Bio Inc. [BXRX] managed to generate an average of -$1,302,280 per employee.Baudax Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.50.
Earnings analysis for Baudax Bio Inc. [BXRX]
With the latest financial reports released by the company, Baudax Bio Inc. posted -0.78/share EPS, while the average EPS was predicted by analysts to be reported at -0.94/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 17.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BXRX.
Insider trade positions for Baudax Bio Inc. [BXRX]
There are presently around $4 million, or 30.80% of BXRX stock, in the hands of institutional investors. The top three institutional holders of BXRX stocks are: NORTH RUN CAPITAL, LP with ownership of 1,009,399, which is approximately -12.42% of the company’s market cap and around 0.20% of the total institutional ownership; CORSAIR CAPITAL MANAGEMENT, L.P., holding 432,752 shares of the stock with an approximate value of $0.48 million in BXRX stocks shares; and VANGUARD GROUP INC, currently with $0.42 million in BXRX stock with ownership of nearly 0.892% of the company’s market capitalization.
Positions in Baudax Bio Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 13 institutional holders increased their position in Baudax Bio Inc. [NASDAQ:BXRX] by around 200,438 shares. Additionally, 30 investors decreased positions by around 1,177,088 shares, while 9 investors held positions by with 2,018,724 shares. The mentioned changes placed institutional holdings at 3,396,250 shares, according to the latest SEC report filing. BXRX stock had 5 new institutional investments in for a total of 89,755 shares, while 17 institutional investors sold positions of 259,216 shares during the same period.